The role of CD1 molecules in immune responses to infection

Current Opinion in Immunology

Volumn 9, Issue 4, 1997, Pages 456-461

  Maher, Juli K ^a   Kronenberg, Mitchell ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CD8 ANTIGEN; MANNOSE RECEPTOR;

HELPER CELL; IMMUNE RESPONSE; INFECTION; MYCOBACTERIUM; REVIEW; TRANSGENIC MOUSE;

EID: 0030874080     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80095-7     Document Type: Article

References (52)

1. Porcelli SA. The CD1 family: a third lineage of antigen-presenting molecules. Adv Immunol. 59:1995;1-98.
2. Castaño AR, Tangri S, Miller JEW, Holcombe HR, Jackson MR, Huse WD, Kronenberg M, Peterson PA. Peptide binding and presenting properties of mouse CD1. Science. 269:1995;223-226.
3. - T lymphocytes to a microbial antigen. Nature. 360:1992;593-597.
4. + T cells. Nature. 372:1994;691-694.
5. Sieling PA, Chatterjee D, Porcelli SA, Prigozy TI, Mazzaccaro RJ, Soriano T, Bloom BR, Brenner MB, Kronenberg M, Brennan PJ, Modlin RL. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science. 269:1995;227-230.
6. Beckman EM, Melian A, Behar SM, Sieling PA, Chatterjee D, Furlong ST, Matsumoto R, Rosat JP, Modlin RL, Porcelli SA. CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. of special interest J Immunol. 157:1996;2795-2803 Demonstration that human CD1c can present nonpeptide antigens. These data indicate that presentation of nonpeptide antigens is not unique to CD1b, and they suggest that different types of nonpeptide antigens could be presented by all CD1 molecules.
7. Calabi F, Bradbury A. The CD1 system. A review. Tissue Antigens. 37:1991;1-9.
8. Hughes AL. Evolutionary origin and diversification of the mammalian CD1 antigen genes. Mol Biol Evol. 8:1991;185-201.
9. 2-microglobulin-independent MHC class lb molecule expressed by human intestinal epithelium. Science. 265:1994;259-262.
10. Colgan SP, Morales VM, Madara JL, Polischuk JE, Balk SP, Blumberg RS. IFN-γ modulates CD1d surface expression on intestinal epithelia. Am J Physiol. 271:1996;C276-C283.
11. Hanau D, Fricker D, Bieber T, Esposito-Farese M-E, Bausinger H, Cazenave J-P, Donato L, Tongio M-M, de la Salle H. CD1 expression is not affected by human peptide transporter deficiency. Hum Immunol. 41:1994;61-68.
12. Brutkiewicz RR, Bennink JR, Yewdell JW, Bendelac A. TAP-independent, β2-microglobulin-dependent surface expression of functional mouse CD1.1. J Exp Med. 182:1995;1913-1919.
13. 2m for stable cell surface expression in T lymphocyte transfectants and thymocytes. Unlike MHC class I molecules, however, mCD1 does not require the transporter associated with antigen processing (TAP) for stable surface expression.
14. Sugita M, Jackman RM, van Donselaar E, Behar SM, Rogers RA, Peters PJ, Brenner MB, Porcelli SA. Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs. of outstanding interest Science. 273:1996;349-352 Provides the first direct evidence that CD1b molecules traffic to late endosomes including the MIIC.
15. Prigozy TI, Sieling PA, Clemens D, Stewart PL, Behar SM, Porcelli SA, Brenner MB, Modlin RL, Kronenberg M. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. of outstanding interest Immunity. 6:1997;187-197 Uptake of LAM by the macrophage receptor is shown to be required for efficient presentation of antigen to lipoglycan-specific CD1b reactive human T cells. LAM, a lipoglycan antigen, and CD1b are shown to traffic to the MIIC and late endosomes. The data suggest that CD1b acquires lipoglycan antigens in an endosomal compartment, and perhaps within the MIIC.
16. + T lymphocytes. Science. 268:1995;863-865.
17. + T cells in major histocompatibility complex class II-deficient mice. J Exp Med. 182:1995;993-1004.
18. Blumberg RS, Gerdes D, Chott A, Porcelli SA, Balk SP. Structure and function of the CD1 family of MHC-like cell surface proteins. Immunol Rev. 147:1995;5-29.
19. Tangri S, Holcombe HR, Castaño AR, Miller JE, Teitell M, Huse WE, Peterson PA, Kronenberg M. Antigen-presenting function of the mouse CD1 molecule. Ann N Y Acad Sci. 778:1996;288-296.
20. - subset. J Exp Med. 177:1993;1763-1771.
21. - cells depend on Fas-mediated apoptosis of their targets. Only killing by granule release reduces the viability of intracellular microorganisms.
22. Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, Melief CJM, Oseroff C, Yuan L, Ruppert J, et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol. 153:1994;5586-5592.
23. Gastinel LN, Simister NE, Bjorkman PJ. Expression and crystallization of a soluble and functional form of an Fc receptor related to class I histocompatibility molecules. Proc Natl Acad Sci USA. 89:1992;638-642.
24. Wang C-R, Castaño AR, Peterson PA, Slaughter C, Fischer-Lindahl K, Deisenhofer J. Nonclassical binding of formylated peptide in crystal structure of the MHC class lb molecule H2-M3. Cell. 82:1995;655-664.
25. Zeng ZH, Castaño AR, Segelke B, Stura EA, Peterson PA, Wilson IA. The crystal structure of murine CD1: an MHC-like fold but with a large hydrophobic antigen binding groove. of outstanding interest Science. 1997; The mCD1 structure provides a biophysical rationale for the ability of CD1 molecules to bind hydrophobic ligands including lipids.
26. Amigorena S, Webster P, Drake J, Newcomb J, Cresswell P, Mellman I. Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J Exp Med. 181:1995;1729-1741.
27. Boniface JJ, Lyons DS, Wettstein DA, Albritton NL, Davis MM. Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced. J Exp Med. 183:1996;119-126.
28. Runnels HA, Moore JC, Jensen PE. A structural transition in class II major histocompatibility complex proteins at mildly acidic pH. J Exp Med. 183:1996;127-136.
29. Collawn JF, Stangel M, Kuhn LA, Esekogwu V, Jing S, Trowbridge IS, Tainer JA. Transferrin receptor internalization sequence YXRF implicates a tight turn as the structural recognition motif for endocytosis. Cell. 63:1990;1061-1072.
30. Clemens DL, Horwitz MA. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med. 181:1995;257-270.
31. Ezekowitz RA, Sastry K, Bailly P, Warner A. Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J Exp Med. 172:1990;1785-1794.
32. Taylor ME, Conary JT, Lennartz MR, Stahl PD, Drickamer K. Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains. J Biol Chem. 265:1990;12156-12162.
33. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol. 13:1995;151-178.
34. Modlin RL. Th1-Th2 paradigm:insights from leprosy. J Invest Dermatol. 102:1994;828-832.
35. - cytolytic T lymphocytes. Nature. 341:1989;447-450.
36. + thymocytes. J Exp Med. 180:1994;395-399.
37. + thymocytes selected by MHC class I molecules. Science. 263:1994;1774-1778.
38. + T cells by non-major histocompatibility complex-encoded class I like molecules expressed on bone marrow derived cells. Proc Natl Acad Sci USA. 92:1995;1200-1204.
39. + T cells by CD1-expressing cortical thymocytes. J Exp Med. 182:1995;2091-2096.
40. - T cells in mice and humans. J Exp Med. 180:1994;1097-1106.
41. - α/β T cells demonstrates preferential use of several Vβ genes and an invariant TCR α chain. J Exp Med. 178:1993;1-16.
42. - T cells. J Exp Med. 180:1994;1171-1176.
43. Davodeau F, Peyrat M-A, Necker A, Dominici R, Blanchard F, Leget C, Gaschet J, Costa P, Jacques Y, Godard A, et al. Close phenotypic and functional similarities between human and murine αβ T cells expressing 'invariant' T cell receptor α chains. J Immunol. 158:1997;5603-5611.
44. pos T cells promptly produce IL-4 in response to in vivo challenge with anti-CD3. J Exp Med. 179:1994;1285-1295.
45. + T cells can, following anti-CD3 antibody stimulation in vivo, mediate IL-4 secretion.
46. + T cells are selected and activated to secrete IL-4 by mCD1. See also [47,48].
47. Mendiratta SK, Martin WD, Hong S, Boesteanu A, Joyce S, Van Kaer L. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. of outstanding interest Immunity. 6:1997;469-477 See annotation [46].
48. + T cell development and early IL-4 production in CD1-deficient mice. of outstanding interest Immunity. 6:1997;459-467 See annotation [46].
49. + T cells in a Th2 response and in immunoglobulin E production. Science. 270:1995;1845-1847.
50. + T cells are not essential for T helper cell 2 immune responses. of outstanding interest J Exp Med. 184:1996;1295-1304 Demonstrates that mCD1 and mCD1-autoreactive T cells are not essential for generating several types of Th2 responses, although they may provide one pathway leading to IL-4 secretion and Th2 immunity. Depending upon the microorganism, such Th2 responses may be essential for clearing the infection, or they may inhibit such clearance. See also [51,52].
51. Guéry J-C, Galbiati F, Smiroldo S, Adorini L. Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and β2-microglobulin-deficient BALB/c mice. of special interest J Exp Med. 183:1996;485-497 See annotation [50].
52. Zhang Y, Rogers KH, Lewis DB. β2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses. of special interest J Exp Med. 184:1996;1507-1512 See annotation [50].